Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24
Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24
高盛以買入評級啓動對Olema Pharmicals的報道,宣佈目標股價爲24美元
Goldman Sachs analyst Richard Law initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Price Target of $24.
高盛分析師理查德·勞以買入評級啓動了對奧萊瑪製藥(納斯達克股票代碼:OLMA)的報道,並宣佈目標股價爲24美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。